Document is current
Any future updates will be listed below
-
Authors
Leguia, Mariana
Vila-Sanjurjo, Antón
Juarez, Diana
Garcia-Glaessner, Alejandra
Gil, Ana I.
Alvarez, Mayita
Cornejo, Rubelio
Cherikh, Sami
Gelber, Casey E.
Goll, Johannes B.
Howard, Leigh M.
Jimenez-Truque, Natalia
Edwards, Kathryn M.
Creech, C. Buddy
Lanata, Claudio F.
-
Funding
Funding for this research was provided by:
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
NIH-NIAID (HSN2722001300023I, Task Order 17)
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 27 March 2025
First Online: 11 August 2025
Competing interests
: All authors (except CFL and KME) declare no financial or non-financial competing interests. CFL has funding from and is a consultant to HilleVax. He is also a member of the Data Safety Monitoring Board of Merck. KME has funding from NIH and CDC and is a consultant for Bionet, Dynavax and IBM. She is also a member of the Data Safety Monitoring Boards of Sanofi, X-4 Pharma, Seqirus, Moderna, Pfizer, Merck, Roche, Novavax, and Brighton Collaboration.
